Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

09/02/2017 ​Hepatitis C Under the Watchful of ALBA Synchrotron 02/02/2017 ​The Barcelona Entrepreneurial Spirit Attracts Important Rounds of Funding 26/01/2017 ​SENER, 50 Years In Space! 19/01/2017 Barcelona Synchrotron Park Even Closer 11/01/2017 ALBA Synchrotron Is Also a Tool for the Environment 05/01/2017 ​Barcelona & Catalonia Startup Hub, the Catalan startups showcase
19 20 21 22 23 24 25 26 27 28 29